Epizyme (EPZM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EPZM Annual Balance Sheets →
This page allows investors to track Epizyme's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2022)
(Mar 31 2022) (Dec 31 2021) (Sep 30 2021) (Jun 30 2021)
Assets
Cash & cash equivalent71.07
Marketable Securities, Current SH73.35
Cash & Short-term Investments144.00
Accounts receivable11.21
Inventories5.54
Prepaid Expense And Other Assets Current25.68
Total Current Assets186.84
Equipment/Property/Plant Net1.05
Intangible Assets40.77
Other Assets, Noncurrent19.00
Operating Lease Right Of Use Asset18.12
Total Assets264.16
Liabilities
Accounts Payable, Current AC5.00
Accrued Liabilities, Current AC24.67
Other Liabilities, Current5.28
Total Current Liabilities34.95
Long-term debt216.89
Total Long-term Debt216.89
Other liabilities, Noncurrent32.60
Operating Lease Liability Current5.28
Operating Lease Liability Noncurrent15.55
Contract With Customer Liability Noncurrent0.46
Related Party Liability Related To Sale Of Future Royalties16.02
Total Liabilities284.44
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock1,311.04
Retained Earnings / Accumulated Deficit-1,331.08
Other Equity-0.25
Common Stockholder's Equity-20.28
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-20.28
Liabilities & Stockholder's Equity264.16
4 historic quarters locked

Sign in to unlock the full Epizyme balance sheet history.

About Epizyme Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-22-015748

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.